Literature DB >> 27151206

KCNK9 imprinting syndrome-further delineation of a possible treatable disorder.

John M Graham1, Neda Zadeh2, Melissa Kelley3, Ee Shien Tan4, Wendy Liew4, Victoria Tan4, Matthew A Deardorff5,6, Golder N Wilson7,8, Lena Sagi-Dain9, Stavit A Shalev9,10.   

Abstract

Patients with KCNK9 imprinting syndrome demonstrate congenital hypotonia, variable cleft palate, normal MRIs and EEGs, delayed development, and feeding problems. Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper lip, palatal abnormalities, and small mandible. This disorder maps to chromosomal region 8q24, and it is caused by a specific missense mutation 770G>A in exon 2, replacing glycine at position 236 by arginine (G236R) in the maternal copy of KCNK9 within this locus. KCNK9 (also called TASK3) encodes a member of the two pore- domain potassium channel (K2P) subfamily. This gene is normally imprinted with paternal silencing, thus a mutation in the maternal copy of the gene will result in disease, whereas a mutation in the paternal copy will have no effect. Exome sequencing in four new patients with developmental delay and central hypotonia revealed de novo G236R mutations. Older members of a previously reported Arab-Israeli family have intellectual disability of variable severity, persistent feeding difficulties in infancy with dysphagia of liquids and dysphonia with a muffled voice in early adulthood, generalized hypotonia, weakness of proximal muscles, elongated face with narrow bitemporal diameter, and reduced facial movements. We describe the clinical features in four recently recognized younger patients and compare them with those found in members of the originally reported Arab-Israeli family and suggest this may be a treatable disorder.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Birk-Barel syndrome; K2P subfamily; K2P9.1; KCNK9; TASK3; cleft palate; flufenamic acid; hypotonia; imprinting disorder; intellectual disability; mefenamic acid; personalized medicine; potassium channel disorder

Mesh:

Substances:

Year:  2016        PMID: 27151206     DOI: 10.1002/ajmg.a.37740

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

Review 1.  Ion Channels in Bone Morphogenetic Protein Signaling.

Authors:  Laura Faith George; Trevor Isner; Emily Anne Bates
Journal:  Bioelectricity       Date:  2019-03-18

2.  Impaired Neurodevelopmental Genes in Slovenian Autistic Children Elucidate the Comorbidity of Autism With Other Developmental Disorders.

Authors:  Danijela Krgovic; Mario Gorenjak; Nika Rihar; Iva Opalic; Spela Stangler Herodez; Hojka Gregoric Kumperscak; Peter Dovc; Nadja Kokalj Vokac
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

3.  Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels.

Authors:  Ehab Al-Moubarak; Emma L Veale; Alistair Mathie
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

4.  Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels.

Authors:  Kevin P Cunningham; D Euan MacIntyre; Alistair Mathie; Emma L Veale
Journal:  Acta Physiol (Oxf)       Date:  2019-09-18       Impact factor: 6.311

5.  Syndromic Disorders Caused by Disturbed Human Imprinting

Authors:  Diana Carli; Evelise Riberi; Giovanni Battista Ferrero; Alessandro Mussa
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-04-10

6.  Inhibition of histone deacetylation rescues phenotype in a mouse model of Birk-Barel intellectual disability syndrome.

Authors:  Tamer Butto; Niklas Hammer; Alexis Cooper; Somanath Jagannath; Desiree Lucia Fend-Guella; Junaid Akhtar; Konstantin Radyushkin; Florian Lesage; Jennifer Winter; Susanne Strand; Jochen Roeper; Ulrich Zechner; Susann Schweiger
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

7.  46,XY,r(8)/45,XY,-8 Mosaicism as a Possible Mechanism of the Imprinted Birk-Barel Syndrome: A Case Study.

Authors:  Anna A Kashevarova; Tatyana V Nikitina; Larisa I Mikhailik; Elena O Belyaeva; Stanislav A Vasilyev; Mariya E Lopatkina; Dmitry A Fedotov; Elizaveta A Fonova; Aleksei A Zarubin; Aleksei A Sivtsev; Nikolay A Skryabin; Lyudmila P Nazarenko; Igor N Lebedev
Journal:  Genes (Basel)       Date:  2020-12-09       Impact factor: 4.096

8.  Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension.

Authors:  Kevin P Cunningham; Robyn G Holden; Pilar M Escribano-Subias; Angel Cogolludo; Emma L Veale; Alistair Mathie
Journal:  J Physiol       Date:  2018-11-24       Impact factor: 5.182

9.  KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma.

Authors:  Wen-Chao Li; Zhi-Yong Xiong; Pin-Zhu Huang; Yang-Jing Liao; Quan-Xi Li; Zhi-Cheng Yao; Ya-Di Liao; Shi-Lei Xu; Hui Zhou; Qing-Liang Wang; He Huang; Peng Zhang; Ji-Zong Lin; Bo Liu; Jie Ren; Kun-Peng Hu
Journal:  Aging (Albany NY)       Date:  2019-10-02       Impact factor: 5.682

10.  Discrimination of DNA Methylation Signal from Background Variation for Clinical Diagnostics.

Authors:  Robersy Sanchez; Xiaodong Yang; Thomas Maher; Sally A Mackenzie
Journal:  Int J Mol Sci       Date:  2019-10-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.